Extended technique for Aging

N/A

Recruiting

Research Sponsored by Erevna Innovations Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to week 7, week 14, week 20, week 28, week 38

Awards & highlights

Study Summary

This trial aims to study the effectiveness and safety of two injection techniques using poly-L-Lactic acid (PLLA) for filling in hollow areas in the temples. The study will focus on how this treatment

Who is the study for?

This trial is for individuals experiencing signs of aging and interested in facial rejuvenation. Participants should be healthy adults willing to undergo injections with poly-L-lactic acid (PLLA) in the temporal region of their face.Check my eligibility

What is being tested?

The study compares two techniques of injecting PLLA: a traditional method targeting just the temporal fossa, versus an experimental technique that includes both the temporal fossa and extends into the hairline. The goal is to see which provides better results in volumizing hollows around temples.See study design

What are the potential side effects?

Potential side effects from PLLA injections may include swelling, redness, pain at injection site, bruising, bumps under the skin, or allergic reactions. These are generally temporary but can vary based on individual response.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to week 7, week 14, week 20, week 28, week 38

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to week 7, week 14, week 20, week 28, week 38

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 7, week 14, week 20, week 28, week 38 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To access the efficacy of the tradition and experimental technique

Secondary outcome measures

To access the safety of the tradition and experimental technique

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Extended techniqueExperimental Treatment1 Intervention

Group II: Traditional techniqueActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Erevna Innovations Inc.Lead Sponsor

12 Previous Clinical Trials

320 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of individuals who are currently enrolled as participants in this medical study?

"Yes, information on clinicaltrials.gov indicates that this study is presently seeking candidates. The trial was initially posted on May 19, 2023, and last revised on March 22, 2024. It aims to enroll 24 participants from a single site."

Answered by AI

Are potential participants currently able to apply for enrollment in this ongoing clinical trial?

"According to clinicaltrials.gov, this medical research endeavor is presently seeking suitable candidates. The initial posting of the trial occurred on May 19th, 2023, with the most recent update noted on March 22nd, 2024."

Answered by AI